Contact
Score Calculators
Publications
Advancing knowledge in chronic liver disease through evidence-based research.
AbstractsPublication policy

Showing 10 of 159 papers

Bacterial and fungal infections in acute-on-chronic liver failure: Prevalence, characteristics and impact on prognosis

Fernández J, Acevedo J, Wiest R, Gustot T, Amoros A, Deulofeu C, Reverter E, Martínez J, Saliba F, Jalan R, Welzel T, Pavesi M, Hernández-Tejero M, Ginès P, Arroyo V; European Foundation for the Study of Chronic Liver Failure.

Gut 2018, 67(10): 1870–1880

DOI: 10.1136/gutjnl-2017-314240

Closed-loop lumped parameter modeling of hemodynamics during cirrhogenesis in rats

Audebert C, Peeters G, Segers P, Laleman W, Monbaliu D, Korf H, Trebicka J, Vignon-Clementel IE, Debbaut C

IEEE Trans Biomed Eng 2018, 65(10): 2311–2322

DOI: 10.1109/TBME.2018.2793948

Quantification of liver fibrosis at T1 and T2 mapping with extracellular volume fraction MRI: Preclinical results

Luetkens JA, Klein S, Träber F, Schmeel FC, Sprinkart AM, Kuetting DLR, Block W, Uschner FE, Schierwagen R, Hittatiya K, Kristiansen G, Gieseke J, Schild HH, Trebicka J, Kukuk GM.

Radiology 2018, 288(3): 748–754

DOI: 10.1148/radiol.2018180051

The prognostic value of acute-on-chronic liver failure during the course of severe alcoholic hepatitis

Sersté T, Cornillie A, Njimi H, Pavesi M, Arroyo V, Putignano A, Weichselbaum L, Deltenre P, Degré D, Trépo E, Moreno C, Gustot T.

J Hepatol 2018, 69(2): 318–324

DOI: 10.1016/j.jhep.2018.02.022

The soluble guanylate cyclase stimulator riociguat reduces fibrogenesis and portal pressure in cirrhotic rats

Schwabl P, Brusilovskaya K, Supper P, Bauer D, Königshofer P, Riedl F, Hayden H, Fuchs CD, Stift J, Oberhuber G, Aschauer S, Bonderman D, Gnad T, Pfeifer A, Uschner FE, Trebicka J, Rohr-Udilova N, Podesser BK, Peck-Radosavljevic M, Trauner M, Reiberger T.

Sci Rep 2018, 8(1): 9372

DOI: 10.1038/s41598-018-27656-y

The use of human albumin in patients with cirrhosis: A European survey

Caraceni P, Pavesi M, Baldassarre M, Bernardi M, Arroyo V.

Expert Rev Gastroenterol Hepatol 2018, 12(6): 625–632

DOI: 10.1080/17474124.2018.1460203

Association between portosystemic shunts and increased complications and mortality in patients with cirrhosis

Simón-Talero M, Roccarina D, Martínez J, Lampichler K, Baiges A, Low G, Llop E, Praktiknjo M, Maurer MH, Zipprich A, Triolo M, Vangrinsven G, Garcia-Martinez R, Dam A, Majumdar A, Picón C, Toth D, Darnell A, Abraldes JG, Lopez M, Kukuk G, Krag A, Bañares R, Laleman W, La Mura V, Ripoll C, Berzigotti A, Trebicka J, Calleja JL, Tandon P, Hernandez-Gea V, Reiberger T, Albillos A, Tsochatzis EA, Augustin S, Genescà J; Baveno VI-SPSS group from the Baveno Cooperation

Gastroenterology 2018, 154(6): 1694–1705.e4

DOI: 10.1053/j.gastro.2018.01.028

Fibroblast growth factor 21 is an early predictor of acute-on-chronic liver failure in critically ill patients with cirrhosis

Ruiz-Margáin A, Pohlmann A, Ryan P, Schierwagen R, Chi-Cervera LA, Jansen C, Mendez-Guerrero O, Flores-García NC, Lehmann J, Torre A, Macías-Rodríguez RU, Trebicka J.

Liver Transpl 2018, 24(5): 595–605

DOI: 10.1002/lt.25041

Severe abnormal heart rate turbulence onset is associated with deterioration of liver cirrhosis

Jansen C, Al-Kassou B, Lehmann J, Pohlmann A, Chang J, Praktiknjo M, Nickenig G, Strassburg CP, Schrickel JW, Andrié R, Linhart M, Trebicka J.

PLoS One 2018, 13(4): e0195631

DOI: 10.1371/journal.pone.0195631

Return-to-health effect of modern combined antiretroviral therapy potentially predisposes HIV patients to hepatic steatosis

Mohr R, Boesecke C, Dold L, Schierwagen R, Schwarze-Zander C, Wasmuth JC, Weisensee I, Rockstroh JK, Trebicka J.

Medicine 2018, 97(17): e0462

DOI: 10.1097/MD.0000000000010462

Registered office

European Foundation for the Study of
Chronic Liver Failure
Travessera de Gràcia 11, 7th floor
08021 Barcelona, Spain

Legal

Contact us

T +34 93 227 14 00
E efclif@efclif.com

© European Foundation for the Study of Chronic Liver Failure 2024